Zimmer Holdings has introduced the TM Ardis Interbody System, which is an application of a porous metal implant with an interbody indication for the lumbar spine. The TM Ardis Interbody System is indicated for use with autogenous bone graft as an intervertebral body fusion device at one or two contiguous levels in the lumbosacral region in the treatment of degenerative disc disease with up to Grade 1 spondylolisthesis or retrolisthesis at the involved levels. The TM Ardis Implant features an updated, anatomical shape which allows the implant to be inserted into the disc space more easily.
More Articles on Zimmer:
Device Makers Get Boost After Biomet Posts Strong 4Q Financials
43 Orthopedic & Spine Devices Receive FDA Clearance in May
12 Spine Device & Implant Launches